Phase 2a Placebo-Controlled Study of VTX3232 Alone or in Combination With Semaglutide in Obesity
Clinical trial NCT06771115 · COMPLETED
Trial details
- NCT number
- NCT06771115
- Sponsor
- Zomagen Biosciences Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-01-07
- Primary completion
- 2025-09-10
- Enrollment
- 176
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.